Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia

Erica K. Barnell,Kenneth F. Newcomer,Zachary L. Skidmore,Kilannin Krysiak,Sydney R. Anderson,Lukas D. Wartman,Stephen T. Oh,John S. Welch,Keith Stockerl-Goldstein,Ravi Vij,Amanda F. Cashen,Iskra Pusic,Peter Westervelt,Camille N. Abboud,Armin Ghobadi,Geoffrey L. Uy,Mark A. Schroeder,John F. DiPersio,Mary C. Politi,David H. Spencer,Eric J. Duncavage,Timothy J. Ley,Malachi Griffith,Meagan A. Jacoby,Obi L. Griffith

Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia

2021

PURPOSEPhysicians treating hematologic malignancies increasingly order targeted sequencing panels to interrogate recurrently mutated genes. The precise impact of these panels on clinical decision m...

Keywords:

Internal medicine
Myeloid leukemia
clinical decision
Oncology
Gene
Physician Decision
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations